Hyperbaric Oxygen Treatment (HBOT) During Methadone Tapering
Opioid Use Disorder
About this trial
This is an interventional supportive care trial for Opioid Use Disorder
Eligibility Criteria
Inclusion Criteria: Enrollment in a supervised opioid treatment program at the Spokane Regional Health District Age greater than 18 years Ability to read, speak, and write English Ability to provide written informed consent. Exclusion Criteria: Pregnancy Any other medical or psychiatric condition that the PI, Co-PI (physician of record) or the Spokane Hyperbaric Center medical director determine might compromise safe study participation in the HBOT clinic (including but not limited to active psychosis, history of frequent psychiatric hospitalizations, severe anxiety with claustrophobia, aggression) Upper respiratory infection Emphysema Air cysts in the lung History of thoracic or ear surgery Taking the medication Antabuse for alcohol addiction High fever.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Full treatment
Partial treatment
Participants are administered 100% oxygen in the HBOT chamber at 2.0 ATA
Participants are administered 21% oxygen in the HBOT chamber at <1.3 ATA.